ÂÜÀòÂÒÂ×

Oliver Hopkinson joined BioEclipse’s Board of Directors in 2019 as a representative of Revelis Capital Group, a Colorado-based venture firm that invests across a range of disruptive, early-stage tech companies. Mr. Hopkinson co-founded Revelis in early 2017, and currently serves as its Managing Principal, overseeing all aspects of its investment operations. To date, Revelis has consummated Series Seed and Series A investments in the biotech, software and data/blockchain sectors. Mr. Hopkinson graduated with a B.S. in Economics from Duke University in 2016, and he is a J.D. candidate at University of Colorado Law School.